Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048397375> ?p ?o ?g. }
- W3048397375 endingPage "30" @default.
- W3048397375 startingPage "17" @default.
- W3048397375 abstract "Both Graves' hyperthyroidism (GH) and Graves' orbitopathy (GO) are associated with significant adverse health consequences. All conventional treatment options have limitations regarding efficacy and safety. Most importantly, they do not specifically address the underlying immunological mechanisms. We aim to review the latest development of treatment approaches in these two closely related disorders.Immunotherapies of GH have recently demonstrated clinical efficacy in preliminary studies. They include ATX-GD-59, an antigen-specific immunotherapy which restores immune tolerance to the thyrotropin receptor; iscalimab, an anti-CD40 monoclonal antibody which blocks the CD40-CD154 costimulatory pathway in B-T cell interaction; and K1-70, a thyrotropin receptor-blocking monoclonal antibody. Novel treatment strategies have also become available in GO. Mycophenolate significantly increased the overall response rate combined with standard glucocorticoid (GC) treatment compared to GC monotherapy. Tocilizumab, an anti-interleukin 6 receptor monoclonal antibody, displayed strong anti-inflammatory action in GC-resistant cases. Teprotumumab, an anti-insulin-like growth factor 1 receptor monoclonal antibody, resulted in remarkable improvement in terms of disease activity, proptosis, and diplopia. Further, rituximab appears to be useful in active disease of recent onset without impending dysthyroid optic neuropathy.Therapeutic advances will continue to optimize our management of GH and associated orbitopathy in an effective and safe manner." @default.
- W3048397375 created "2020-08-18" @default.
- W3048397375 creator A5059970375 @default.
- W3048397375 creator A5087797414 @default.
- W3048397375 date "2020-01-01" @default.
- W3048397375 modified "2023-10-15" @default.
- W3048397375 title "Novel Approaches for Immunosuppression in Graves’ Hyperthyroidism and Associated Orbitopathy" @default.
- W3048397375 cites W1485275533 @default.
- W3048397375 cites W1505110999 @default.
- W3048397375 cites W1562512263 @default.
- W3048397375 cites W1794369351 @default.
- W3048397375 cites W1930521840 @default.
- W3048397375 cites W1940562968 @default.
- W3048397375 cites W1964994168 @default.
- W3048397375 cites W1969029810 @default.
- W3048397375 cites W1969343496 @default.
- W3048397375 cites W2005305700 @default.
- W3048397375 cites W2006991322 @default.
- W3048397375 cites W2016741516 @default.
- W3048397375 cites W2020071485 @default.
- W3048397375 cites W2020862624 @default.
- W3048397375 cites W2022276421 @default.
- W3048397375 cites W2024419938 @default.
- W3048397375 cites W2039119197 @default.
- W3048397375 cites W2052463348 @default.
- W3048397375 cites W2052931193 @default.
- W3048397375 cites W2055237014 @default.
- W3048397375 cites W2057482557 @default.
- W3048397375 cites W2057742899 @default.
- W3048397375 cites W2062970882 @default.
- W3048397375 cites W2063530353 @default.
- W3048397375 cites W2083600248 @default.
- W3048397375 cites W2083681450 @default.
- W3048397375 cites W2087234492 @default.
- W3048397375 cites W2091089626 @default.
- W3048397375 cites W2093134054 @default.
- W3048397375 cites W2099402970 @default.
- W3048397375 cites W2101657267 @default.
- W3048397375 cites W2104844142 @default.
- W3048397375 cites W2111127355 @default.
- W3048397375 cites W2114545174 @default.
- W3048397375 cites W2117488028 @default.
- W3048397375 cites W2120985321 @default.
- W3048397375 cites W2124682453 @default.
- W3048397375 cites W2137496300 @default.
- W3048397375 cites W2145253402 @default.
- W3048397375 cites W2145497832 @default.
- W3048397375 cites W2147032331 @default.
- W3048397375 cites W2149848264 @default.
- W3048397375 cites W2151135812 @default.
- W3048397375 cites W2157437551 @default.
- W3048397375 cites W2158064334 @default.
- W3048397375 cites W2166592840 @default.
- W3048397375 cites W2174893517 @default.
- W3048397375 cites W2255614352 @default.
- W3048397375 cites W2288910126 @default.
- W3048397375 cites W2337910696 @default.
- W3048397375 cites W2360627571 @default.
- W3048397375 cites W2414609028 @default.
- W3048397375 cites W2429858838 @default.
- W3048397375 cites W2487648087 @default.
- W3048397375 cites W2528970629 @default.
- W3048397375 cites W2568452461 @default.
- W3048397375 cites W2586168297 @default.
- W3048397375 cites W2592429441 @default.
- W3048397375 cites W2611131029 @default.
- W3048397375 cites W2724708752 @default.
- W3048397375 cites W2743949118 @default.
- W3048397375 cites W2750317963 @default.
- W3048397375 cites W2786397131 @default.
- W3048397375 cites W2788394845 @default.
- W3048397375 cites W2796624271 @default.
- W3048397375 cites W2799361100 @default.
- W3048397375 cites W2801141326 @default.
- W3048397375 cites W2809713645 @default.
- W3048397375 cites W2855676216 @default.
- W3048397375 cites W2884675353 @default.
- W3048397375 cites W2885162095 @default.
- W3048397375 cites W2885962121 @default.
- W3048397375 cites W2887073360 @default.
- W3048397375 cites W2888628819 @default.
- W3048397375 cites W2890125925 @default.
- W3048397375 cites W2891159041 @default.
- W3048397375 cites W2892025512 @default.
- W3048397375 cites W2896207908 @default.
- W3048397375 cites W2901733456 @default.
- W3048397375 cites W2902098691 @default.
- W3048397375 cites W2902638510 @default.
- W3048397375 cites W2905619963 @default.
- W3048397375 cites W2912714306 @default.
- W3048397375 cites W2921390768 @default.
- W3048397375 cites W2941619090 @default.
- W3048397375 cites W2950800950 @default.
- W3048397375 cites W2965455433 @default.
- W3048397375 cites W2973052335 @default.
- W3048397375 cites W2973648524 @default.
- W3048397375 cites W2995047063 @default.
- W3048397375 cites W2995626205 @default.